They said "Robust" pain relief was achieved with just one injection, 95% pain reduction with multiple injections. Name another company who can say that, you going to argue with the FDA?
The Trial Doctors
These are the people who met with the patients each week and month during the trials around the world. These doctors all said that Ampion performed beyond anyone's expectations and amazed them as a group. You can read their comments on your own time. Are you going to argue with the trial doctors?
We all saw the slide at the annual shareholder's meeting where Ampion grew fingers of cartilage. Ever seen another company show anything like that? Anywhere?
Are you going to argue with the science?
We are well funded through the BLA. We have a plant that is ready in all ways to churn out millions of dosages of Ampion. We have news of pivotal trials on our two leading drugs within days or weeks. We'll know of MRI data that no other trials have utilized for OAK. We have zero debt. Management has sold no shares other than gifts from Bar Or I believe. We are covered by Citi and Jefferies sometimes favorably sometimes unfavorably. When the news comes out we'll be covered by the world. Are you going to argue with company readiness?
Stock price potential
Currently it would take a rough 300% gain just to get back in price to where we were this year. We have a burdensome short load at two trading weeks to cover and major coincident demand for shares when news comes out that we'll see share prices in the 20s to 30s in minutes. We have all seen this before in other stocks, we sold off by over 6 million shares when they came out with news on cheesy frozen samples, imagine when 12 million or so shorts cover.
Are you going to argue with price potential?
You take any arguments up with me..... anytime you want.
Mr. Bill is back, yea missed you buddy.
I read on Clinical trial dot gov where this study is over a year further in duration on ONLY subjects With Mild to Moderate knee pain. Amino peptide based and they won't declare any results for over a year. Now we are due all kinds of data on Ampion by then in pivotal trial info for the filing of the BLA.
There is no competition possible from Orthotrophix.
Dr. Bar Or did explain his MRI preferences and allowed that the as the joint changed the 12-20 week data would allow them a way to determine the location and further study of that location of joint change, re read the last press release.
Mr. Bill please realize there is no further downside on this stock that we are due news on. The upside on this stock was over $10 bucks just in the last year, so that is a rough 300% gain to get to just where we were... imagine where we'll be when 12 million of your shorty buddies scramble madly to cover.
Good luck to you and the cabal in that event.
Very let down by a lackluster response. You took time to make alot of declarative statements only one of which is true.
1)Optina will be competitive when the news comes out. We adjusted dosage to better reflect patient's BMI. Easy to doubt any drug prior to the news of efficacy which will be coming out very soon.
2)Zertane is currently worth less than an IPO should bring. It is prudent to wait for more of a price advantage at that point. Zertane is not on our balance sheet or income statement and got us today where we'll be tomorrow.
3) Still pushing goat studies does not equate to any near term competition, and saline shots do evacuate synovial debris, but Ampion does this by repairing the joint and perhaps rebuilds cartilage over time let alone lowering pain at the joint by 95%. Who else can say that?
4) Every PR is legally scripted as all bio PR's are. Ampio's PR's are no different, except we'd like results now, right now, but as I have said before I am in no hurry. Neither should you be, so stop whining.
5) Open label results could come any day. We are deep into Q4 so they are compiling data and wording the report right now. Strut will follow that so we have those reports and Optina coming out between now and January or February, so the report on the Super 7 is not our only leg to stand on. Your negative slant reeks of the cabal.
Basically your efforts while appreciated (because I waited all day), basically you were very lazy explaining to us why Ampion is on the ropes. I expect more from a cabal member.
Ya ok, we are to believe you that this stock is not manipulated, ya ok, you are the only person that ever defends HFT, hedge funds or shorting. Investors like me and the new investors in the very near future that we'll be introduced to..... we as a group don't like folks like you and your bretheren, as you are not the chosen ones, the investors in Ampio are. We are long and proud to be so, we contribute to the growth of the company, all short shills ever contribute is funk here and there for personal gain, my money will shortly be in the field helping millions of patients with severe joint pain, and I will toast this heartily in Jamaica while you try to figure out what happened to your short portfolio.
200/13600 retracted stock subsequently went up four cents in short order, if you look at a daily chart on low volume days and compare it to other small bio's you would be amazed at the days trade ups and downs, manipulated yes, but not for long, the news will add a whole new investor class and they are not in and out five times a day, no, they hang around for years and our drugs work well and we'll all find that out in the days ahead.
Two hours and nothing from Trusty on why he "thinks Ampion is on the ropes"
Hmm that is really plenty of time to figure something out, now One of the bear brothers has to help him out with some nonsense, jeesh what is the board coming to when a negative poster can't back up his stuff with facts?
Complete wierdo, so your "beliefs" are more valid than legalpress releases from the company and we are to believe you over trial doctors, and FDA clinical reps and FDA reviews of data?
I just quote facts, not "beliefs" like you wierdo.....back on ignore for a couple weeks so you can talk smack behind my back all you want.... kinda embarassing for you really~
Very noisy little man you are.
An hour and a half is plenty of time to tell us all how Ampion is on the ropes, but nah, you just thought you'd throw that out there, I'll stand by and wait a bit more let you come up with a few things there bud.
So according to you wierdo, we are not due a report on the unblinded Super 7 this quarter, which by the way is nearly over, and are you saying we don't have a 95% level of pain reduction with multiple injections, are you saying that doesn't correlate with joint repair, are you saying that doesn't then correlate with cartilage regeneration? I am saying you are noisy with your go nowhere negative posts, none of which are about the company--just me, you are a loud mouth short shill that people otherwise don't care about, but for me... you are sport.
This above is the story of where we will be, from where we've been.
Our annual high on this stock is over $10 per share or over 300% to get back to where we were, imagine where we'll be a short while from now!
And then there is Trusty, just how is it that Ampion is on the ropes?
A 95% reduction in knee pain for the worst patients in just 12-20 weeks? Come on what ropes are you teetering on? Vyrix will likely IPO when the market welcomes new investment, either way that has nothing to do with the future of Ampio Pharmaceuticals now does it, Zertane got us to where we will be...you should be thankful.
Unless you are short somehow, or perhaps one of Bill's doppelgangers, we really have little idea about the background of many posters here, but as you know
I remain steadfast in support of Ampio and will not allow any detractors to blow baloney, if this includes you in the future then I will expect you to indicate that I must be delusional, or psyco, or something, but you just said Ampion was on the ropes and I say you sir blew some baloney with no substantive info otherwise, please explain yourself.
As you are one of the chief manipulators here, I suspect in your opinion that there is zero manipulation of Ampio Pharmaceuticals.
Normal trading huh, my buddies in the trade review dpt. of the SEC have forwarded time stamped trade data to the appropriate departments for further investigation. I will follow up with you in particular as to when the results become available.
We are due a report on the Super 7 this quarter, or basically any day, as well as Optina thereafter. We have never had any bad news on the performance of these drugs, just some cheesy frozen samples months ago. The FDA knows Ampion rocks, and would likely get us to market sooner as we have every potential to indicate joint repair, most likely through cartilage regeneration. Any day this news comes out, and two trading weeks for the shorts to cover, where would they find over 12 million shares to buy?
The truth remains.
Here are the actual violations of section 4c(a)(5)(C) of the Commodity Exchange Act
On July 22, 2013, the U.S. Commodity Futures Trading Commission (CFTC) filed and settled its first case under the Dodd-Frank Act’s prohibition of the disruptive practice of spoofing by bidding or offering with intent to cancel before execution. For the first time, a deceptive use of high frequency trading (often called “HFT”) in the derivatives market was identified and the individuals responsible for the trading activity were punished, critics of pinging argue that it enables traders to manipulate prices by issuing flash bids and then canceling them within one second, showing other traders a false “best bid/offer.
Quote stuffing is the process of placing multiple orders in the market, in some instances millions of orders, simultaneously only to quickly cancel them to drive the price up or down in one’s favor. Pinging and quote stuffing are similar in that they employ HFT to bid and cancel orders to get the best available price. The key difference between quote stuffing and pinging is that the intent of quote stuffing is to alter the price of the underlying contract on the market, whereas the intent of pinging is to find the limit of another trader and take advantage of that trader, with the possible side-effect of altering the price of the contract. Quote stuffing is undoubtedly a form of manipulation, as it involves intentionally floating non bona fide orders (bids and offers that were intended to be canceled) into the market place to bend the market to one’s favor. The manipulative power of quote stuffing has garnered the attention of the FBI, which announced in 2013 that it was cooperating with the Quantitative Analytics Unit at the SEC to investigate potential abuses arising from quote stuffing in dark pools. Pinging is truly manipulative while pinging orders are often placed witwithout the intent of executing them.
Bid/Offer retractions may or may not be legitimate, we'll see
The reverse stack, where if that offer is retracted would bring the price up a penny perhaps if a 50 share order was bot above. If they short in the morning, roll out some funk on the board and then quick cover and ride up a few cents.
As an investor I wonder....... is that investing?
Rule 10b-21 naked short selling anti-fraud rule. The new rule, which became effective at 12:01 a.m. ET on Sept. 18, 2008, covers short sellers who deceive broker-dealers or any other market participants about their intention or ability to deliver securities in time for settlement. The rule makes clear that such persons are violating the law when they fail to deliver.
You and your boss Bill are fond of goat studies, I suggest you invest in that company and leave us all here alone, thought you would fade away by now.